Angiotensin 2 for AKI After OLT | MicrobiomeTrials← Back to trialsNCT04592744
Angiotensin 2 for AKI After OLT
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2022-04-08Est. Completion: 2026-12
Enrollment target: 30 participants Locations- Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine, Los Angeles, California, United States
Other microbiome trials you might be interested in
Hepatitis C, ChronicFibrosis
Viral hepatitis C prognosis is related to the presence of a fibrosis and to the risk of developing cirrhosis or hepatic …
Pessac, FranceCompleted Dec 2008
Hematopoietic Stem Cell Transplant
Background:
Hematopoietic stem cell transplant (HSCT) is a common treatment for many cancers and other illnesses. But m…
Bethesda, United StatesEst. completion Jun 30, 2031
Phase 2
Recruiting
Intrahepatic Cholangiocarcinoma (Icc)
Intrahepatic Cholangiocarcinoma (ICC), the second most prevalent primary malignant liver neoplasm, features highly aggre…
Tianjin, ChinaEst. completion Dec 31, 2027